Business / Finance

RSS
Adeona to sell 2.85 million common stock at $1.40 per share

Adeona to sell 2.85 million common stock at $1.40 per share

Covalon Technologies' annual revenue up 54%

Covalon Technologies' annual revenue up 54%

Athersys enters definitive agreements to sell common stock, warrants

Athersys enters definitive agreements to sell common stock, warrants

BGU, PTT sign R&D collaboration agreement for commercial development of green algae strain

BGU, PTT sign R&D collaboration agreement for commercial development of green algae strain

Awarepoint ends 2010 with 91 hospital sites contract containing RTLS network coverage

Awarepoint ends 2010 with 91 hospital sites contract containing RTLS network coverage

BioTime announces acquisition of CTI assets

BioTime announces acquisition of CTI assets

Synutra International renews manufacturing license for its primary production facility

Synutra International renews manufacturing license for its primary production facility

XDx establishes $12.5 million multi-draw term loan facility with GE Capital

XDx establishes $12.5 million multi-draw term loan facility with GE Capital

IDEXX Laboratories fourth quarter revenues increase 5% to $283.8 million

IDEXX Laboratories fourth quarter revenues increase 5% to $283.8 million

H.I.G. urges Matrixx shareholders to evaluate BML Letter regarding pending tender offer

H.I.G. urges Matrixx shareholders to evaluate BML Letter regarding pending tender offer

Taro fourth quarter net sales increase 22.7% to $102.2 million

Taro fourth quarter net sales increase 22.7% to $102.2 million

EHSI examines business plans and product lines of OceanBASIS

EHSI examines business plans and product lines of OceanBASIS

Quality Systems third quarter net revenues increase 23% to record $91.9 million

Quality Systems third quarter net revenues increase 23% to record $91.9 million

Bioniche Life Sciences joins Australian Securities Exchange

Bioniche Life Sciences joins Australian Securities Exchange

Arena reduces workforce by 25% and provides update on lorcaserin

Arena reduces workforce by 25% and provides update on lorcaserin

Inovio to use proceeds from $24.3M offering for development of DNA vaccine against cervical dysplasias

Inovio to use proceeds from $24.3M offering for development of DNA vaccine against cervical dysplasias

Tibotec grants multiple non-exclusive licenses to generic manufacturers for rilpivirine hydrochloride

Tibotec grants multiple non-exclusive licenses to generic manufacturers for rilpivirine hydrochloride

Pfizer announces termination of HSR waiting period for acquisition of King

Pfizer announces termination of HSR waiting period for acquisition of King

Zimmer fourth quarter net sales increase 2.5% to $1.13 billion

Zimmer fourth quarter net sales increase 2.5% to $1.13 billion

Fresenius Medical Care prices US$ senior notes

Fresenius Medical Care prices US$ senior notes